Spyre Therapeutics (NASDAQ:SYRE) Issues Quarterly Earnings Results, Misses Expectations By $0.04 EPS
Spyre Therapeutics (NASDAQ:SYRE – Get Free Report) released its quarterly earnings results on Thursday. The company reported ($0.70) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.66) by ($0.04), FiscalAI reports. Spyre Therapeutics Trading Up 3.3% Shares of NASDAQ:SYRE traded up $1.21 during trading on Thursday, hitting $37.81. 803,801 shares of [...]
